Roselabs Finance

{
  "main_header": {
    "sid": 397394,
    "name": "Roselabs Finance",
    "stock_name": "Roselabs Finance",
    "full_name": "Roselabs Finance Ltd",
    "name_url": "stocks-analysis/roselabs-finance",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "22.57",
    "chg": -1.18,
    "chgp": "-4.97%",
    "dir": -1,
    "prev_price": "23.75",
    "mcapval": "24.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531324,
    "symbol": "",
    "ind_name": "Non Banking Financial Company (NBFC)",
    "ind_code": 5,
    "indexname": "",
    "isin": "INE475C01012",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "56 ",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/roselabs-finance-397394-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Roselabs Finance Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-roselabs-finance-ltd-latest-results-good-or-bad-3798961",
        "imagepath": "",
        "date": "2026-01-21 19:13:40",
        "description": "Roselabs Finance Ltd's latest financial results for Q3 FY26 present a complex picture. The company reported net sales of ₹1.21 crores, marking its first revenue generation in three quarters, following two consecutive quarters of zero sales. This indicates some level of operational activity, although the sustainability of this revenue remains uncertain given the prior performance.\n\nThe net loss for the quarter was ₹0.04 crores, which reflects a quarter-on-quarter improvement of 33.33% from the previous loss of ₹0.06 crores. Despite this improvement, the company continues to face significant challenges, as indicated by its negative operating profit margin of -2.48% and persistent losses over multiple quarters. The operating profit before depreciation, interest, and tax also showed a slight reduction in loss, reaching ₹-0.03 crores, which is the least negative figure in recent quarters.\n\nThe financial health o..."
      },
      {
        "title": "Roselabs Finance Q3 FY26: Mounting Losses Deepen Financial Distress",
        "link": "https://www.marketsmojo.com/news/result-analysis/roselabs-finance-q3-fy26-mounting-losses-deepen-financial-distress-3797027",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/RoselabsFinance_quaterlyResult_3797027.png",
        "date": "2026-01-20 19:15:59",
        "description": "Roselabs Finance Limited, the micro-cap non-banking financial company under the Lodha Group umbrella, reported a quarterly net loss of ₹0.04 crores for Q3 FY26 (October-December 2025), marking a marginal improvement from the ₹0.06 crore loss in Q2 FY26. With a market capitalisation of just ₹27.00 crores and a deeply negative book value of ₹-4.73 per share, the company remains entrenched in severe financial distress despite sporadic revenue generation."
      },
      {
        "title": "Why is Roselabs Finance Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-roselabs-finance-ltd-fallingrising-3787619",
        "imagepath": "",
        "date": "2026-01-10 01:16:22",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Outperformance</strong></p>\n<p>Roselabs Finance’s recent price surge is underscored by its strong relative performance against key benchmarks. Over the past week, the stock gained 5.48%, significantly outperforming the Sensex, which declined by 2.55% during the same period. Year-to-date, the stock has advanced 7.58%, while the Sensex has fallen 1.93%. This divergence highlights investor interest in Roselabs Finance despite broader market weakness.</p>\n<p>On the day in question, the stock opened with a gap up of 4.98%, reaching an intraday high of Rs 22.15. However, it also experienced volatility, touching a low of Rs 20.05, indicating a wide trading range of Rs 2.10. Despite this fluctuation, the weighted average price suggests that more volume was traded..."
      },
      {
        "title": "Roselabs Finance Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/roselabs-finance-ltd-is-rated-strong-sell-3771104",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/RoselabsFinance_mojoScore_3771104.png",
        "date": "2025-12-26 15:12:32",
        "description": "Roselabs Finance Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 Oct 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 December 2025, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Roselabs Finance Stock Falls to 52-Week Low of Rs.19.86 Amidst Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/roselabs-finance-stock-hits-52-week-low-amidst-continued-downtrend-3753856",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/RoselabsFinance_priceRelatedfactors_3753856.png",
        "date": "2025-12-09 11:42:40",
        "description": "Roselabs Finance has reached a new 52-week low of Rs.19.86, marking a significant decline in its share price amid a broader market environment where the Sensex trades near its yearly highs. The stock’s performance contrasts sharply with the overall market trend, reflecting ongoing concerns within the Non Banking Financial Company (NBFC) sector."
      },
      {
        "title": "Roselabs Finance Sees Revision in Market Evaluation Amidst Challenging Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/roselabs-finance-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3750588",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/RoselabsFinance_mojoScore_3750588.png",
        "date": "2025-12-08 10:10:34",
        "description": "Roselabs Finance, a microcap player in the Non Banking Financial Company (NBFC) sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The recent assessment highlights shifts across key analytical parameters, signalling a cautious stance among market observers."
      },
      {
        "title": "Roselabs Finance Falls to 52-Week Low of Rs.20.9 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/roselabs-finance-stock-falls-to-52-week-low-of-rs-209-amid-continued-downtrend-3748816",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/RoselabsFinance_priceRelatedfactors_3748816.png",
        "date": "2025-12-05 11:15:55",
        "description": "Roselabs Finance has reached a fresh 52-week low of Rs.20.9 today, marking a significant milestone in its recent price trajectory. The stock has experienced a sustained decline over the past several sessions, reflecting ongoing pressures within the Non Banking Financial Company (NBFC) sector and company-specific factors."
      },
      {
        "title": "Roselabs Finance Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/roselabs-finance-plunges-to-lower-circuit-amid-unrelenting-selling-pressure-3748734",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/RoselabsFinance_only_sellers_3748734.png",
        "date": "2025-12-05 10:35:17",
        "description": "Roselabs Finance Ltd has encountered significant selling pressure, with the stock hitting a fresh 52-week low of Rs 20.9 and registering a day decline of 5.00%, markedly underperforming the Sensex which showed a marginal gain of 0.08%. The absence of buyers and a narrow trading range underscore a distress selling scenario, reflecting ongoing investor concerns in the Non Banking Financial Company (NBFC) sector."
      },
      {
        "title": "Roselabs Finance Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/roselabs-finance-faces-severe-selling-pressure-hits-lower-circuit-amid-market-downturn-3746931",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/RoselabsFinance_only_sellers_3746931.png",
        "date": "2025-12-04 15:20:15",
        "description": "Roselabs Finance Ltd is currently experiencing severe selling pressure, with the stock registering a sharp decline and no buying interest visible in the market. The company’s shares have fallen for three consecutive sessions, reflecting distress selling signals and a challenging environment for this Non Banking Financial Company (NBFC)."
      }
    ],
    "total": 206,
    "sid": "397394",
    "stock_news_url": "https://www.marketsmojo.com/news/roselabs-finance-397394"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "21-Jan-2026",
      "details": "Newspaper publication of the financial results for the quarter and nine months ended December 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Unaudited Financial Results Of The Company Along With Limited Review Report For The Quarter And Nine Months Ended December 31 2025",
      "datetime": "20-Jan-2026",
      "details": "Unaudited Financial Results of the Company along with Limited Review Report for the quarter and nine months ended December 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Financial Results Of The Company Along With Limited Review Report For The Quarter And Nine Months Ended December 31 2025",
      "datetime": "20-Jan-2026",
      "details": "Unaudited Financial Results of the Company along with Limited Review Report for the quarter and nine months ended December 31 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Roselabs Finance Ltd latest results good or bad?

2026-01-21 19:13:40

Roselabs Finance Ltd's latest financial results for Q3 FY26 present a complex picture. The company reported net sales of ₹1.21 crores, marking its first revenue generation in three quarters, following two consecutive quarters of zero sales. This indicates some level of operational activity, although the sustainability of this revenue remains uncertain given the prior performance. The net loss for the quarter was ₹0.04 crores, which reflects a quarter-on-quarter improvement of 33.33% from the previous loss of ₹0.06 crores. Despite this improvement, the company continues to face significant challenges, as indicated by its negative operating profit margin of -2.48% and persistent losses over multiple quarters. The operating profit before depreciation, interest, and tax also showed a slight reduction in loss, reaching ₹-0.03 crores, which is the least negative figure in recent quarters. The financial health o...

Read full news article

Roselabs Finance Q3 FY26: Mounting Losses Deepen Financial Distress

2026-01-20 19:15:59

Roselabs Finance Limited, the micro-cap non-banking financial company under the Lodha Group umbrella, reported a quarterly net loss of ₹0.04 crores for Q3 FY26 (October-December 2025), marking a marginal improvement from the ₹0.06 crore loss in Q2 FY26. With a market capitalisation of just ₹27.00 crores and a deeply negative book value of ₹-4.73 per share, the company remains entrenched in severe financial distress despite sporadic revenue generation.

Read full news article

Why is Roselabs Finance Ltd falling/rising?

2026-01-10 01:16:22

Short-Term Price Movement and Market Outperformance

Roselabs Finance’s recent price surge is underscored by its strong relative performance against key benchmarks. Over the past week, the stock gained 5.48%, significantly outperforming the Sensex, which declined by 2.55% during the same period. Year-to-date, the stock has advanced 7.58%, while the Sensex has fallen 1.93%. This divergence highlights investor interest in Roselabs Finance despite broader market weakness.

On the day in question, the stock opened with a gap up of 4.98%, reaching an intraday high of Rs 22.15. However, it also experienced volatility, touching a low of Rs 20.05, indicating a wide trading range of Rs 2.10. Despite this fluctuation, the weighted average price suggests that more volume was traded...

Read full news article

Roselabs Finance Ltd is Rated Strong Sell

2025-12-26 15:12:32

Roselabs Finance Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 Oct 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 December 2025, providing investors with the latest insights into its performance and outlook.

Read full news article

Roselabs Finance Stock Falls to 52-Week Low of Rs.19.86 Amidst Market Pressure

2025-12-09 11:42:40

Roselabs Finance has reached a new 52-week low of Rs.19.86, marking a significant decline in its share price amid a broader market environment where the Sensex trades near its yearly highs. The stock’s performance contrasts sharply with the overall market trend, reflecting ongoing concerns within the Non Banking Financial Company (NBFC) sector.

Read full news article

Roselabs Finance Sees Revision in Market Evaluation Amidst Challenging Financial Trends

2025-12-08 10:10:34

Roselabs Finance, a microcap player in the Non Banking Financial Company (NBFC) sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The recent assessment highlights shifts across key analytical parameters, signalling a cautious stance among market observers.

Read full news article

Roselabs Finance Falls to 52-Week Low of Rs.20.9 Amidst Prolonged Downtrend

2025-12-05 11:15:55

Roselabs Finance has reached a fresh 52-week low of Rs.20.9 today, marking a significant milestone in its recent price trajectory. The stock has experienced a sustained decline over the past several sessions, reflecting ongoing pressures within the Non Banking Financial Company (NBFC) sector and company-specific factors.

Read full news article

Roselabs Finance Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-05 10:35:17

Roselabs Finance Ltd has encountered significant selling pressure, with the stock hitting a fresh 52-week low of Rs 20.9 and registering a day decline of 5.00%, markedly underperforming the Sensex which showed a marginal gain of 0.08%. The absence of buyers and a narrow trading range underscore a distress selling scenario, reflecting ongoing investor concerns in the Non Banking Financial Company (NBFC) sector.

Read full news article

Roselabs Finance Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-04 15:20:15

Roselabs Finance Ltd is currently experiencing severe selling pressure, with the stock registering a sharp decline and no buying interest visible in the market. The company’s shares have fallen for three consecutive sessions, reflecting distress selling signals and a challenging environment for this Non Banking Financial Company (NBFC).

Read full news article

View All News